ASCENDIS PHARMA A/S - ADR (ASND)
US04351P1012 - ADR
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -370.67M | -481.45M | -583.19M | -383.58M | -418.96M | |||
| Depreciation Amortization | 14.37M | 18.91M | 17.95M | 15.40M | 9.45M | |||
| Change In Working Capital | -106.14M | -129.06M | -19.64M | -46.91M | -50.00K | |||
| Interest Paid | 14.76M | 15.67M | 9.29M | 1.84M | 1.50M | |||
| Taxes Paid | 4.50M | 4.47M | 0.00 | -150.00K | -1.10M | |||
| Other non cash items | 142.01M | 124.24M | 89.18M | -2.56M | 138.01M | |||
| OPERATING CASH FLOW | -320.42M | -467.36M | -495.70M | -417.65M | -271.55M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.35M | -2.44M | -14.49M | -24.23M | -21.55M | |||
| Other Investing Activity | 77.19M | 288.92M | 76.22M | -86.35M | -269.65M | |||
| INVESTING CASH FLOW | 75.83M | 286.47M | 61.73M | -110.58M | -291.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 128.39M | 125.82M | 496.93M | -6.43M | -4.77M | |||
| Stock Issued/Repurchased | 8.44M | 10.29M | -100.15M | 357.82M | 638.80M | |||
| Other Financing Activity | N/A | -1.81M | N/A | N/A | -31.37M | |||
| FINANCING CASH FLOW | 135.01M | 134.29M | 396.77M | 351.39M | 602.65M | |||
| Exchange Rate Effect | 386.08K | -6.01M | 35.69M | 38.59M | -53.49M | |||
| CHANGE IN CASH | -109.19M | -52.60M | -1.51M | -138.25M | -13.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -320.42M | -467.36M | -495.70M | -417.65M | -271.55M | |||
| Capital Expenditure | -1.35M | -2.44M | -14.49M | -24.23M | -21.55M | |||
| FREE CASH FLOW | -321.77M | -469.80M | -510.19M | -441.88M | -293.10M | |||
All data in EUR